DRUG DISCOVERY

INSIGHTS ON DRUG DISCOVERY

  • Unlock Oral Delivery Potential For Macromolecules With A Parallel Screening Approach

    Identifying the optimal formulation and dose form which shows an increase more than 20 times in the oral bioavailability of Salmon Calcitonin.

  • Leverage The Internet Of Things Within The Laboratory

    As science-based organizations look to leverage the internet of things (IoT) within the laboratory, careful consideration must be given to available technologies, data formats, and platforms. 

  • Electronic Lab Notebook Supports Scientific Knowledge Management In R&D

    One tool holds a unique position among R&D informatics systems -- electronic laboratory notebooks (ELNs). ELNs both produce data and consume information and are particularly powerful.

  • Route Scouting In API Development: A Luxury Or Necessity?

    Until about 30 years ago, “process R&D” in the pharmaceutical market meant just making a chemical process scalable. Most of the brightest chemists chose to spend their time “discovering” molecules rather than studying how to make them on scale, both efficiently and safely. Adequate attention was not paid to critical aspects of scale-up like safety, waste management, or energy efficiency. The pharmaceutical industry even justified their methods by hypothesizing that the benefit of the end product (life-saving medicines) far outweighed the concerns over the amount of waste that was generated. As a result, the pharmaceutical industry became one of the worst-performing sectors in terms of waste produced per unit of product made. Over the years, the pharma industry has recognized the need to change and develop more efficient processes. Thus a new field of chemistry called process research was born.

  • End-to-end Technology Transfer Services In Oral Solids And Sterile

    Technology transfer involves manufacturing drug product with increasing batch sizes on larger equipment or using continuous processing on pilot scale equipment.

More Insights On Drug Discovery

DRUG DISCOVERY MULTIMEDIA

  • The Cost of Failure In Pharma Development: A Risk for Everyone

    Predicting potential problems serves no purpose if it is not accompanied by adequate corrective actions or mitigation strategies to address them. This webinar will also discuss risk mitigation options for both early and late stage development programs.

More Drug Discovery Multimedia

DRUG DISCOVERY SOLUTIONS

  • High Potency API (HPAPI) Development & Manufacturing Brochure

    Piramal Pharma Solutions (PPS) is pleased to welcome Ash Stevens LLC as a part of the Piramal Group. Leveraging five decades of Ash Stevens’s operational experience and technical expertise, Piramal’s service offering now includes High Potency API (HPAPI) development and manufacturing capabilities. Located in Riverview, USA, our state-of the-art FDA licensed cGMP facility offers a full range of scale and containment options for high potency API manufacturing.

  • High Potency API (HPAPI) Development & Manufacturing
    High Potency API (HPAPI) Development & Manufacturing

    Piramal Pharma Solutions (PPS) is pleased to welcome Ash Stevens LLC as a part of the Piramal Group. Leveraging five decades of Ash Stevens’s operational experience and technical expertise, Piramal’s service offering now includes High Potency API (HPAPI) development and manufacturing capabilities. Located in Riverview, USA, our state-of the-art FDA licensed cGMP facility offers a full range of scale and containment options for high potency API manufacturing.

  • CDMO For All Phases Of The Drug Life Cycle
    CDMO For All Phases Of The Drug Life Cycle

    Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal Enterprises Ltd with a vast network of development and manufacturing facilities located in North America, Europe and Asia. 

More From Drug Discovery Solutions

DRUG DISCOVERY & OUTSOURCED PHARMA EVENTS

24th Annual Validation Week October 22 - 24, 2018
San Diego, CA)
IRT 2018 October 22 - 23, 2018
Philadelphia, PA)
eCOA/ePRO 2018 October 23, 2018
Philadelphia, PA)